Ideaya Biosciences Inc (IDYA) Stock Analysis

Sector: HEALTHCARE - BIOTECHNOLOGY

Exchange: NASDAQ

Key Metrics

• Price: $31.90
• Market Cap: $2.78B
• EPS: $-1.28
• 52-Week High: $39.28
• 52-Week Low: $13.45

Market Sentiment

Ideaya Biosciences Inc currently has a Bullish sentiment score of 0.46.

About Ideaya Biosciences Inc

Ideaya Biosciences, Inc. (NASDAQ: IDYA) is a leading precision medicine oncology company based in South San Francisco, California, focused on developing targeted therapies that optimize patient outcomes through molecular diagnostics. The company specializes in the concept of synthetic lethality, creating innovative treatments that specifically target cancer cells with unique genetic markers, thereby addressing significant unmet needs in oncology. By combining its expertise in advanced biomark...

GNG Research provides proprietary Safety Scores, Quality Scores, Fair Value estimates, and Valuation Ratings for Ideaya Biosciences Inc and 4,500+ other companies. Learn more about GNG Pro.

Frequently Asked Questions

Does IDYA pay dividends?

Ideaya Biosciences Inc (IDYA) does not currently pay a regular dividend.

What is IDYA's market cap?

Ideaya Biosciences Inc (IDYA) has a market capitalization of $2.78B with a current stock price of $31.90.